rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2009-2-9
|
pubmed:abstractText |
Mean insulin resistance (IR) is greater and it is also more variable in overweight women with polycystic ovarian syndrome (PCOS) compared to weight matched controls. Whilst treatment will reduce the mean IR, it is not known if the IR variability is also reduced.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1365-2265
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
70
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
233-7
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:18547343-Adult,
pubmed-meshheading:18547343-Anti-Obesity Agents,
pubmed-meshheading:18547343-Body Mass Index,
pubmed-meshheading:18547343-Female,
pubmed-meshheading:18547343-Humans,
pubmed-meshheading:18547343-Hyperandrogenism,
pubmed-meshheading:18547343-Hypoglycemic Agents,
pubmed-meshheading:18547343-Insulin,
pubmed-meshheading:18547343-Insulin Resistance,
pubmed-meshheading:18547343-Lactones,
pubmed-meshheading:18547343-Metformin,
pubmed-meshheading:18547343-Polycystic Ovary Syndrome,
pubmed-meshheading:18547343-Thiazolidinediones,
pubmed-meshheading:18547343-Treatment Outcome
|
pubmed:year |
2009
|
pubmed:articleTitle |
Effect of metformin, orlistat and pioglitazone treatment on mean insulin resistance and its biological variability in polycystic ovary syndrome.
|
pubmed:affiliation |
Department of Medicine, University of Hull, Hull, UK. l.cho@hull.ac.uk
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial
|